Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron for CINV prevention in pediatric patients
NCT01442376Phase 3Completed
- Sponsor
- Helsinn
- Start
- Sep 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Helsinn. Started Sep 2011; status: completed.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01442376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01442376.